Mucosal‐associated invariant T cells in digestive tract: Local guardians or destroyers?

Abstract

AbstractMucosa‐associated invariant T cells (MAIT) are a class of innate‐like T lymphocytes mainly presenting CD8+ phenotype with a semi‐invariant αβ T‐cell receptor, which specifically recognises MR1‐presented biosynthetic derivatives of riboflavin synthesis produced by various types of microbiomes. As innate‐like T lymphocytes, MAIT can be activated by a variety of cytokines, leading to immediate immune responses to infection and tumour cues. As an organ that communicates with the external environment, the digestive tract, especially the gastrointestinal tract, contains abundant microbial populations. Communication between MAIT and local microbiomes is important for the homeostasis of mucosal immunity. In addition, accumulating evidence suggests changes in the abundance and structure of the microbial community during inflammation and tumorigenesis plays a critical role in disease progress partly through their impact on MAIT development and function. Therefore, it is essential for the understanding of MAIT response and their interaction with microbiomes in the digestive tract. Here, we summarised MAIT characteristics in the digestive tract and its alteration facing inflammation and tumour, raising that targeting MAIT can be a candidate for treatment of gastrointestinal diseases.